191
|
|
|
Growth factor independent 1B transcriptional repressor |
BDPLT17, ZNF163B |
|
192
|
|
|
G elongation factor mitochondrial 1 |
COXPD1, EFG, EFG1, EFGM, EGF1, GFM, hEFG1, mtEF-G1 |
|
193
|
|
|
GTP dependent ribosome recycling factor mitochondrial 2 |
EF-G2mt, EFG2, MRRF2, MST027, MSTP027, RRF, RRF2, RRF2mt, hEFG2, mEF-G 2 |
|
194
|
|
|
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
ADG-90, C6orf114 |
|
195
|
|
|
Gfo/Idh/MocA-like oxidoreductase domain containing 2 |
- |
|
196
|
|
|
Glutamine--fructose-6-phosphate transaminase 1 |
CMS12, CMSTA1, GFA, GFAT, GFAT 1, GFAT1, GFAT1m, GFPT, GFPT1L, MSLG |
|
197
|
|
|
Glutamine-fructose-6-phosphate transaminase 2 |
GFAT, GFAT 2, GFAT2 |
|
198
|
|
|
GDNF family receptor alpha 1 |
GDNFR, GDNFR-alpha-1, GDNFRA, GFR-ALPHA-1, GFRalpha-1, RET1L, RETL1, RHDA4, TRNR1 |
|
199
|
|
|
GDNF family receptor alpha 2 |
GDNFRB, NRTNR-ALPHA, NTNRA, RETL2, TRNR2 |
Asthma, Color vision deficiency, Dementia, Frontotemporal dementia, Lung cancer, Non-small cell lung carcinoma, Pelvic organ prolapse, Prostate cancer, Schizophrenia, Squamous cell carcinoma, Stevens-johnson syndrome, Toxic epidermal necrolysis |
200
|
|
|
GDNF family receptor alpha 3 |
GDNFR3 |
|